Discover success in remediation! Explore how Planet Pharma tackled challenges for a medical devices manufacturer, transforming obstacles into victories. Read the case study now!
Olivia Gomez’s Post
More Relevant Posts
-
How do you harness the power of medical innovations while simultaneously battling spiralling costs? 💉🩺 Advent's expert team breaks down some of the biggest challenges and trends facing the pharma space in our ultimate pharma guide: https://lnkd.in/eH_W3x2h
To view or add a comment, sign in
-
Collaborating with leaders in academia, biopharma, and government, Resilience is working to improve the way complex medicines are made. We’ve introduced entirely new definitions of “flexible” and “adaptive” to make it possible for more patients to get the medicines they need from our North America facilities. Want to discuss our aligned incentives approach to rapid tech transfer, flexible commitments, and if we can meet your timelines? Start a conversation: https://hubs.ly/Q02v4tm20
To view or add a comment, sign in
-
-
Collaborating with leaders in academia, biopharma, and government, Resilience is working to improve the way complex medicines are made. We’ve introduced entirely new definitions of “flexible” and “adaptive” to make it possible for more patients to get the medicines they need from our North America facilities. Want to discuss our aligned incentives approach to rapid tech transfer, flexible commitments, and if we can meet your timelines? Start a conversation: https://hubs.ly/Q02snrSg0
Find out more about our North America facilities
To view or add a comment, sign in
-
Market leaders such as Roche Diagnostics USA, Thermo Fisher Scientific, Quest Diagnostics, and Siemens Healthineers are at the forefront of innovation in the 𝗜𝗻 𝗩𝗶𝘁𝗿𝗼 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 (𝗜𝗩𝗗) 𝗺𝗮𝗿𝗸𝗲𝘁. Recent developments, such as QIAGEN's FDA clearance for the NeuMoDx CT/NG Assay 2.0 and Newland EMEA's introduction of a fresh IVD product line, demonstrate the sector's commitment to advancing healthcare. Regulatory bodies like the FDA and EMA ensure product safety and quality, shaping market standards. Collaboration between industry leaders and research institutions drives innovation, ensuring that the IVD market remains dynamic and responsive to emerging healthcare challenges. Learn more: https://lnkd.in/e34MDsvh #IVDMarket #DiagnosticTechnology #HealthcareInnovation #MedicalDevices #MarketResearch #SkyQuest
To view or add a comment, sign in
-
-
Highly-Crosslinked Business Development Manager, Box Opener, Device Nation Podcast, Electric Guitar!
Very thoughtful post, I couldn’t stop listening! Humble opinion, the future belongs to those organizations and leaders with properly oriented directional arrows! The inwardly focused rep/team lead/management/CEO see themself as the “hero of the story” ➡️⬅️ and decline is the inevitable result. Why? If all I see is ME, whether I’m an individual or a corporate entity, I am no longer aligned with my customers that are actually generating revenue. Posturing, social media preening, corporate grandstanding, political climbing, all of these things take our focus off the real hero of this story…..our surgeons and the facilities they work in. “Outward Arrows”, on the other hand, is a posture that’s all about PEOPLE ⬅️➡️. This one word is what’s separating many companies losing ground from the ones seeing growth in this challenging market. One in particular is kicking butt right now on this singular principle!! It’s not always “THE” answer, but it is absolutely “A” Answer, and we ignore it at our peril. Who’s the hero of your story? Have a great weekend!!! 🎸😃 #devicenation
Expert in MedTech StartUps and Surgical Robotics. And F'in good at it. AI - digital health - endovascular robotics - neurovascular robotics - cardiac robotics - future of healthcare. NED - Board Advisor - investor
"Why do you think many of the once great MedTech companies are going so badly?" I was asked this question last week. Some of the biggest and the best are not in a good place - no matter what people spin. On my morning walk I've given my thoughts on why... Agree? Disagree? You have other reasons you think it's broken? Comment below... Just my opinions... #medtech #medicaldevices #intutive Intuitive #johnsonandjohnsonmedtech Johnson & Johnson MedTech#medtronic Medtronic #GEHealthcare GE HealthCare Siemens Healthineers #siemenshealthineers Boston Scientific #bostonscientific BD #BD Stryker #stryker Abbott #Abbott Baxter International Inc. #baxter Fresenius Medical Care Terumo Medical Corporation Zimmer Biomet #zimmer Olympus Corporation
To view or add a comment, sign in
-
Maybe I’m old fashioned, but I I fully agree. The big ones moves in the same direction and doesn’t dare to explore their own pathway. Using BCG, who streamline the whole industry! Instead we should invest in #Education #Healteconomics #Patientsafety #Elivatinghealthcare #Realbusinessunderstanding
Expert in MedTech StartUps and Surgical Robotics. And F'in good at it. AI - digital health - endovascular robotics - neurovascular robotics - cardiac robotics - future of healthcare. NED - Board Advisor - investor
"Why do you think many of the once great MedTech companies are going so badly?" I was asked this question last week. Some of the biggest and the best are not in a good place - no matter what people spin. On my morning walk I've given my thoughts on why... Agree? Disagree? You have other reasons you think it's broken? Comment below... Just my opinions... #medtech #medicaldevices #intutive Intuitive #johnsonandjohnsonmedtech Johnson & Johnson MedTech#medtronic Medtronic #GEHealthcare GE HealthCare Siemens Healthineers #siemenshealthineers Boston Scientific #bostonscientific BD #BD Stryker #stryker Abbott #Abbott Baxter International Inc. #baxter Fresenius Medical Care Terumo Medical Corporation Zimmer Biomet #zimmer Olympus Corporation
To view or add a comment, sign in
-
Great insights in this whitepaper that don’t only apply to CDx but AI-powered diagnostics. Don’t select your partner just on their ability to develop the diagnostic, but also on their ability to help you commercialize it. Too often there is a lack of adoption because commercialization is an afterthought. #precisionmedicine #diagnostics #artificialintelligence
Are you ready to overcome the challenges of companion diagnostics (CDx) commercialization? Our white paper, 'The path to success in precision medicine: market access for CDx,' provides insights based on real-world experiences. https://lnkd.in/gEr5fTzJ #pharmaceutical , #pharma , #biopharma , #cdx , #precisionmedicine , #companiondiagnostic, #diagnostics , #diagnostictesting , #medicaldevices
Download the white paper today!
questdiagnostics.com
To view or add a comment, sign in
-
Please join us on Sept 12th for this insightful discussion on best practices for reverification season!
Register now: https://loom.ly/L3Auzbw Only one day left to register for our webinar, Rethink Your Annual Reverification Strategy: No More Blizzards, happening live tomorrow at 1 p.m. ET. Join Apellis Pharmaceuticals' Patient Services Director Tasha Scott, JM DREW, LLC's Founder & Managing Member, Jim Drew, and AssistRx's Vice President of Business Development, Brok W. Vandersteen, for a deep dive into how the right annual reverification strategy balances tech + talent to meet program goals. #InformedAccess #ImprovedOutcomes
To view or add a comment, sign in
-
-
From our series "Marcom’s Favorite Events," Alin, our team's most tech-savvy member, shares his insights on his favorite event in the Pharma industry. Watch until the end to get the full picture of this exciting event!
To view or add a comment, sign in